Biosignatures in thrombotic disorders.
Becker
Richard C
RC
Cardiology and Hematology, Duke University School of Medicine, USA.
D001241:Aspirin / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D020869:Gene Expression Profiling; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D011237:Predictive Value of Tests; D012307:Risk Factors; D013927:Thrombosis / Q000175:diagnosis* / Q000235:genetics; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives
D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin